|
SMG7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.142600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.118030E-01 |
| Normal-vs-Stage2 |
7.571200E-01 |
| Normal-vs-Stage3 |
1.474590E-01 |
| Normal-vs-Stage4 |
1.896610E-01 |
| Stage1-vs-Stage2 |
4.523800E-01 |
| Stage1-vs-Stage3 |
2.103900E-03 |
| Stage1-vs-Stage4 |
7.440200E-03 |
| Stage2-vs-Stage3 |
1.582150E-01 |
| Stage2-vs-Stage4 |
1.940800E-01 |
| Stage3-vs-Stage4 |
9.701800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.660200E-01 |
| Normal-vs-AfricanAmerican |
3.300200E-01 |
| Normal-vs-Asian |
2.147200E-01 |
| Caucasian-vs-AfricanAmerican |
2.572200E-01 |
| Caucasian-vs-Asian |
1.548570E-01 |
| AfricanAmerican-vs-Asian |
4.307600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.383600E-01 |
| Normal-vs-Female |
2.616000E-01 |
| Male-vs-Female |
8.725600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.311000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.964000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.475600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.497200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.961000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.039200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.903000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.891400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.547200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.159600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.759300E-03 |
| Normal-vs-Grade 2 |
2.086200E-01 |
| Normal-vs-Grade 3 |
9.523600E-01 |
| Normal-vs-Grade 4 |
1.165520E-02 |
| Grade 1-vs-Grade 2 |
8.842100E-02 |
| Grade 1-vs-Grade 3 |
4.124100E-02 |
| Grade 1-vs-Grade 4 |
3.380200E-04 |
| Grade 2-vs-Grade 3 |
1.545630E-01 |
| Grade 2-vs-Grade 4 |
2.766700E-04 |
| Grade 3-vs-Grade 4 |
9.175600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.155000E-04 |
| Normal-vs-ccB subtype |
7.586300E-02 |
| ccA subtype-vs-ccB subtype |
5.14590003941606E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.278800E-01 |
| Normal-vs-N1 |
4.782600E-01 |
| N0-vs-N1 |
6.636200E-01 |
|
|
